CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/21.06.24 Stock

Warrant

DE000GG26LC7

Market Closed - BOERSE MUENCHEN 02:26:47 2024-05-22 pm EDT
0.056 EUR +7.69% Intraday chart for CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/21.06.24
Current month+93.10%
1 month+194.74%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.056 +7.69%
24-05-21 0.052 +4.00%
24-05-20 0.05 +35.14%
24-05-17 0.037 -33.93%
24-05-16 0.056 -40.43%

Real-time BOERSE MUENCHEN

Last update May 22, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer Goldman Sachs
WKN GG26LC
ISINDE000GG26LC7
Date issued 2024-01-24
Strike 20 $
Maturity 2024-06-21 (30 Days)
Parity 1 : 1
Emission price 0.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.094
Lowest since issue 0.01
Delta0.09x
Omega 19.62
Premium18.93x
Gearing226.07x
Moneyness 0.8440
Difference Strike 3.12 $
Difference Strike %+15.60%
Spread 0.02
Spread %25.32%
Theoretical value 0.0690
Implied Volatility 40.58 %
Total Loss Probability 93.04 %
Intrinsic value 0.000000
Present value 0.0690
Break even 20.07 €
Theta-0.03x
Vega0.01x
Rho0x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88 USD
Average target price
17.34 USD
Spread / Average Target
+2.70%
Consensus